What You Should Know: - Today, World Economic Forum announced that 39 organizations have signed the Global Health Equity Network Zero Health Gaps Pledge. - The pledge includes 10 key commitments all signatories have made to embed health equity principles throughout their operations, workforce and guiding philosophies. It marks the beginning of an historic journey to making health equity an integral part of business strategies globally and an important step towards a world without health
Read More
COTA Appoints Noel Alaka as VP of Life Sciences
What You Should Know: Today, oncology real-world data analytics company COTA announced the appointment of Noel Alaka as Vice President of Life Sciences. As VP of Life Sciences, Alaka will be responsible for helping grow and build partnerships with leading life sciences companies that are looking to adopt real-world data and real-world evidence to help accelerate innovation in treatments for patients facing cancer. Noel Alaka Bio/Background A benchtop
Read More
Sanofi Taps Yseop to Accelerate Medical Writing and Reporting Processes
What You Should Know: - Yseop, an artificial intelligence (AI) software company and pioneer in Natural Language Processing (NLP), today announced that Sanofi, the global healthcare company, has chosen to scale its natural language generation (NLG) capabilities with Yseop. - Sanofi will use the platform to accelerate its clinical study submission processes and bring new treatments to patients faster. - Sanofi plans to continue to expand the use of the Yseop
Read More
Sanofi Launches Its First Digital Health Accelerator to Address Unmet Patient Needs
What You Should Know: - Sanofi launched its first Digital Accelerator to better leverage data and artificial intelligence to develop solutions that address unmet patient needs. - The Digital Accelerator team is developing an integrated platform and data solution to enhance awareness of atopic dermatitis and available treatment options amongst patients and HCPs. Digital Accelerator Focus The Digital Accelerator is the next step in Sanofi’s
Read More
DarioHealth Forms $30M Strategic Agreement with Sanofi U.S.
What You Should Know: - DarioHealth Corp., a provider of global digital therapeutics (DTx), announced it has entered into a $30M multi-year, strategic agreement with Sanofi U.S., an innovative global healthcare company. The multi-year, $30 million-dollar agreement will help accelerate commercial adoption of Dario's full suite of digital therapeutics and drive the expansion of digital health solutions on the Dario platform. - As part of the strategic agreement, Dario and Sanofi will
Read More
Sanofi Taps BrightInsight for Development of Software as a Medical Device
What You Should Know: - Sanofi, a global biopharmaceutical company focused on human health has inked a strategic partnership with BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated digital health solution to bring to market a next-generation digital companion application for one of Sanofi’s products. - The BrightInsight® Platform has been selected to serve as the underlying infrastructure to accelerate continuous development of one of Sanofi’s
Read More
Ginger Lands $50M to Expand On-Demand Mental Health Support Platform
What You Should Know: - Ginger announces $50 Million in Series D funding to expand
access to its on-demand mental healthcare system led by Advance Venture
Partners and Bessemer Venture Partners; joined by Cigna Ventures and existing
investors. - Company has more than tripled revenue over the past year, now brings access to on-demand mental healthcare to millions around the world through 200+ employer clients and leading health plans. Ginger, a San Francisco, CA-based provider of
Read More
Analysis: Applying AI in the Fight Against The Coronavirus
Drug discovery is a notoriously long, complex and expensive process requiring the concerted efforts of the world’s brightest minds. The complexity in understanding human physiology and molecular mechanisms is increasing with every new research paper published and for every new compound tested. As the world is facing a new challenge in trying to both adapt to and defend itself against the coronavirus, artificial intelligence is offering new hope that a cure might be developed faster than ever
Read More
Abbott and Sanofi Partner to Integrate Glucose Sensing and Insulin Data
- Abbott (ABT) and Sanofi partner to integrate to developing tools that combine the FreeStyle Libre technology with Sanofi′s insulin dosing information for future smartpens, insulin titration apps and cloud software. - The integration will enable both people with diabetes and their doctors to make better-informed treatment decisions around medication, nutrition, and lifestyle.Abbott (ABT) and Sanofi, today announced they are partnering to integrate glucose sensing and insulin delivery
Read More
Sanofi and Google to Establish Virtual Healthcare Innovation Lab Focused on AI-Enabled Datasets
French pharmaceutical company Sanofi and Google today announced its plan to establish a new virtual Innovation Lab that will leverage emerging data technologies to spur the transformation of healthcare delivery. The partnership will change how Sanofi develops new treatments and will focus on three key objectives1. Better understand patients and diseases,2. Incease Sanofi’s operational efficiency3. Improve the experience of Sanofi’s patients and customersVirtual Innovation Lab
Read More
